Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Turner

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Structure and function of P2 purinoceptersG A Weisman, J T Turner, J S Fedan
European Journal of Morphology|November 24, 1998
Development and characterization of immortalized rat parotid and submandibular acinar cell linesD O Quissell, J T Turner, R S Redman
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalizationJ T Turner, D W Bollinger, M L Toews
Molecular Pharmacology|November 1, 1985
Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclaseJ T Turner, C Ray-Prenger, D B Bylund
Journal of Community Psychology|June 11, 1977
A survey of community perceptions of critical life situations and community helping sources as a tool for mental health program developmentJ T Turner, W W Kimbrough, R N Traynham
Life Sciences|September 24, 1984
Alpha-2 adrenergic regulation of norepinephrine release in the rat submandibular gland as measured by HPLC-ECJ T Turner, D L Pierce, D B Bylund
The Journal of Biological Chemistry|April 25, 1989
Regulation of Na+/K+/Cl- cotransport and [3H]bumetanide binding site density by phorbol esters in HT29 cellsC C Franklin, J T Turner, H D Kim
Peptides|September 1, 1986
A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29J T Turner, S B Jones, D B Bylund
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1990
Regulation of the neurotensin receptor and intracellular calcium mobilization in HT29 cellsJ T Turner, M R James-Kracke, J M Camden
The American Journal of Physiology|January 1, 1991
Regulation of calcium-activated potassium efflux by neurotensin and other agents in HT-29 cellsH Wu, C C Franklin, H D Kim, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Structure and function of P2 purinoceptersG A Weisman, J T Turner, J S Fedan
European Journal of Morphology|November 24, 1998
Development and characterization of immortalized rat parotid and submandibular acinar cell linesD O Quissell, J T Turner, R S Redman
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalizationJ T Turner, D W Bollinger, M L Toews
Molecular Pharmacology|November 1, 1985
Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclaseJ T Turner, C Ray-Prenger, D B Bylund
Journal of Community Psychology|June 11, 1977
A survey of community perceptions of critical life situations and community helping sources as a tool for mental health program developmentJ T Turner, W W Kimbrough, R N Traynham
Life Sciences|September 24, 1984
Alpha-2 adrenergic regulation of norepinephrine release in the rat submandibular gland as measured by HPLC-ECJ T Turner, D L Pierce, D B Bylund
The Journal of Biological Chemistry|April 25, 1989
Regulation of Na+/K+/Cl- cotransport and [3H]bumetanide binding site density by phorbol esters in HT29 cellsC C Franklin, J T Turner, H D Kim
Peptides|September 1, 1986
A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29J T Turner, S B Jones, D B Bylund
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1990
Regulation of the neurotensin receptor and intracellular calcium mobilization in HT29 cellsJ T Turner, M R James-Kracke, J M Camden
The American Journal of Physiology|January 1, 1991
Regulation of calcium-activated potassium efflux by neurotensin and other agents in HT-29 cellsH Wu, C C Franklin, H D Kim, et al.
Pageof 8